The contemporary medical landscape across the United States, United Kingdom, Germany, Japan, China, Canada, France, Netherlands, Switzerland, Australia, Dubai, Finland, and Austria is experiencing a transformative reassessment of unconventional psychoactive compounds. As clinical investigators and public health authorities seek innovative therapeutic models for treatment-resistant psychological conditions, researchers increasingly analyze substances that challenge traditional pharmaceutical paradigms. […]